Clinical Trial

Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds

Study acronym: DXP01
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Purpose of this study is the demonstration of safety and efficacy of the dermal fillers DXP01 Face for restoration of moderate to severe nasolabial folds
Trial Details
NCT Number NCT06885775
Lead Sponsor DEXLEVO
Conditions Dermal Fillers, Nasolabial Folds, Wrinkles
Enrollment 80 participants
Start Date 2025-04-28
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-20